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ABSTRACT
Adipose tissue is an abundant source of multipotent progenitor cells that have shown promise in regenerative medicine. In humans, fat is primarily distributed in the subcutaneous and visceral depots,
which have varying biochemical and functional properties. In most studies to date, subcutaneous
adipose tissue has been investigated as the adipose-derived stem cell (ASC) source. In this study,
we sought to develop a broader understanding of the influence of specific adipose tissue depots
on the isolated ASC populations through a systematic comparison of donor-matched abdominal subcutaneous fat and omentum, and donor-matched pericardial adipose tissue and thymic remnant
samples. We found depot-dependent and donor-dependent variability in the yield, viability, immunophenotype, clonogenic potential, doubling time, and adipogenic and osteogenic differentiation capacities of the ASC populations. More specifically, ASCs isolated from both intrathoracic depots had a longer
average doubling time and a significantly higher proportion of CD34+ cells at passage 2, as compared
with cells isolated from subcutaneous fat or the omentum. Furthermore, ASCs from subcutaneous
and pericardial adipose tissue demonstrated enhanced adipogenic differentiation capacity, whereas
ASCs isolated from the omentum displayed the highest levels of osteogenic markers in culture. Through
cell culture analysis under hypoxic (5% O2) conditions, oxygen tension was shown to be a key mediator of
colony-forming unit-fibroblast number and osteogenesis for all depots. Overall, our results suggest that
depot selection is an important factor to consider when applying ASCs in tissue-specific cell-based regenerative therapies, and also highlight pericardial adipose tissue as a potential new ASC source. STEM
CELLS TRANSLATIONAL MEDICINE 2014;3:206–217

INTRODUCTION
Human adipose tissue is an abundant source of regenerative cells, termed adipose-derived stem
cells (ASCs), which are being investigated in the
laboratory and in preclinical trials for a broad
range of cell-based therapies [1, 2]. An important
regenerative mechanism for ASCs is the secretion
of paracrine factors that modulate biological
responses, including apoptosis, angiogenesis, inflammation, and matrix remodeling [3–5]. Furthermore, ASCs have been demonstrated to
have an immune-privileged status, as well as an
immunomodulatory capacity [6–8]. In terms of
differentiation potential, ASCs are a heterogeneous population that includes multipotent stem
cells that can differentiate into cells derived from
the mesoderm, with mostliterature to date focused
on the adipogenic, osteogenic, and chondrogenic
lineages. However, studies have demonstrated
plasticity toward other lineages, including endothelial [9], epithelial [10], hepatocyte [11], and
neural [12, 13] populations.

In developing fat as a cell source for clinical
applications, it is important to consider the effects
of depot and donor variability. Adipose tissue is
found throughout the human body and can generally be subdivided into the subcutaneous and visceral depots. The comparative studies to date
have begun to explore the differences in ASC populations isolated from subcutaneous adipose tissue at varying anatomical locations, as well as
from the omentum [14–17]. These studies have indicated that the specific tissue source can influence the characteristics of the extracted cell
populations. In particular, Schipper et al. [17] isolated ASCs from subcutaneous adipose tissue at
different sites and observed variations in proliferation that were dependent on donor age, as well
as depot-dependent differences in apoptotic susceptibility and lipolytic function. Immunophenotype analysis by flow cytometry has also indicated
that ASCs from different sites can have varying surface marker expression profiles [16]. Moreover,
several studies have found that the adipogenic
and osteogenic differentiation potential in culture
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varies for ASCs derived from subcutaneous fat versus the omentum
[16, 18].
In addition to the omentum, visceral adipose tissue is found
within the intrathoracic region. Recently, human epicardial adipose
tissue was explored as a regenerative cell source in the treatment of
myocardial infarction [19]. However, pericardial adipose tissue and
the thymic remnant are intrathoracic depots that are anatomically
distinct (Fig. 1), which have not yet been characterized as potential
ASC sources. Whereas epicardial fat is continuous with the myocardium and shares the same microcirculation, the pericardial depot is
more anteriorly located and anatomically separated from the heart
muscle [20]. Similarly, the thymic remnant is derived from the thymus, which undergoes atrophy starting in the third year of life, culminating with its substitution with adipose tissue [21, 22]. In the
context of cardiac surgery, pericardial adipose tissue and thymic
remnant represent accessible and expendable fat sources for cell
therapies to promote cardiovascular regeneration.
With a view toward optimizing depot selection in the development of ASC-based therapies, our primary objective was to conduct
a broad range of in vitro characterization studies to assess depotdependent variability in the ASC populations isolated from donormatched subcutaneous adipose tissue and omentum, as well as
donor-matched pericardial adipose tissue and thymic remnant. A
secondary goal was to investigate the effects of oxygen tension
during culture on ASC clonogenic potential, proliferation, and
adipogenic/osteogenic differentiation by comparing the responses
under normoxic (95% air/5% CO2) and hypoxic (5% O2/90% N2/5%
CO2) conditions. Oxygen tension is emerging as a key mediator of
mesenchymal stem cells (MSCs), and hypoxia can influence MSC
proliferation [23, 24], apoptosis [25], and differentiation [26, 27]
through hypoxia-inducible transcription factors. Preconditioning
stem cells under hypoxic conditions has been investigated as
a means of promoting a proangiogenic phenotype to enhance
the regenerative potential of the cells for cardiovascular applications [28, 29]. Moreover, studies have indicated that hypoxia can
impede the osteogenic differentiation of subcutaneous ASCs [26,
30], although the effects on adipogenesis are not well understood
[31]. As such, we were interested in exploring whether hypoxia
could be a key influencing factor on ASC proliferation and differentiation for all of the depot sources.

MATERIALS AND METHODS
Materials
Unless otherwise stated, all chemicals were purchased from SigmaAldrich Canada (Oakville, Canada) and used as received. All human
adipose tissue samples were collected en bloc at the Kingston General Hospital and Hotel Dieu Hospital in Kingston, Canada. Research
ethics board approval was obtained from Queen’s University (REB
CHEM-002-07). Matched abdominal subcutaneous and omentum
adipose tissue samples were collected from single sites with informed consent from patients undergoing bowel surgery (N = 14
donors), and matched pericardial and thymic remnant adipose tissue samples were obtained during open-heart surgery in a second
group of patients (N = 24 donors). The samples were transported to
the laboratory on ice in sterile phosphate-buffered saline (PBS) supplemented with 2% bovine serum albumin (BSA) and processed
within 2 h. The patient gender, age, and body mass index (BMI)
were recorded (supplemental online Table 1). For all assays, the
number of replicate samples for each donor (n) and the number
of repeat trials with cells from different donors (N) are reported.
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Histological Analysis
Tissue samples were fixed in 10% neutral buffered formalin, paraffin embedded, and sectioned for Masson’s trichrome staining.

Cell Isolation and Yield
Primary human ASCs were isolated using published protocols,
with all tissue sources processed using identical methods [32].
The viable cell yield in the stromal vascular fraction (SVF) was estimated for all depots (n = 3, N = 7) using the Guava ViaCount assay
(Millipore, Billerica, MA) with analysis with a Guava easyCyte 8HT
flow cytometer. The yield for each sample was normalized to the
digested tissue mass.

ASC Culture
The SVF was plated on tissue culture flasks (Corning 75 cm2; Fisher
Scientific, Oakville, Canada) at 30,000 cells/cm2 in growth medium
comprised of DMEM:Ham’s F12 supplemented with 10% fetal bovine serum (HyClone, Logan, UT; Fisher Scientific), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (1% pen-strep; Life Technologies,
Burlington, Canada). The cells were cultured in a standard CO2 incubator (37°C, 5% CO2). After 24 hours, nonadherent cells were removed through PBS rinsing. The growth medium was changed
every 2–3 days, and the cells were passaged at 80% confluence. Passage 2 (P2) cells were used for all culture analyses.

Immunophenotype Characterization
Flow cytometry analysis was performed on P2 ASCs (n = 3, N = 6) using a Guava easyCyte 8HT flow cytometer. Single marker staining was
performed with monoclonal, fluorochrome-conjugated antibodies
from eBioscience (San Diego, CA), as follows: CD34-APC (catalogue
17-0349-41), CD31-phycoerythrin (PE; catalogue 12-0319-41), CD44PE-Cy7 (catalogue 25-0441-81), CD90-fluorescein isothiocyanate
(FITC; catalogue 11-0909-41), CD29-PE (catalogue 12-0299-71),
CD73-FITC (catalogue 11-0739-41), CD4-PE (catalogue 12-004941), and CD166-PE-Cy7 (catalogue 46-1668-41). All samples were
stained for 30 minutes at 4°C and protected from light. Following incubation, the cells were fixed in 0.5% paraformaldehyde for 15
minutes at 4°C. Unstained controls were included in every trial.

In Vitro Clonogenic Potential
Colony-forming unit-fibroblast (CFU-F) assays were performed on
P2 ASCs (n = 3, N = 3) using established protocols [33]. Briefly, ASCs
were plated at 100 cells per 100 mm diameter tissue culture dish in
growth medium and cultured under normoxic (95% air/5% CO2)
and hypoxic (5% O2/90% N2/5% CO2) conditions, using a ProOx
110 oxygen controller and subchamber system (Biospherix, Lacona,
NY), with medium changes every 3 days. At 14 days, the cells were
stained with 0.5% crystal violet in methanol. Stained colonies having a diameter $5 mm were counted, and the colony-forming efficiency (CFE) was calculated as the total number of colonies per 100
seeded cells.

ASC Proliferation
The proliferative capacity of P2 ASCs was assessed under normoxic (95% air/5% CO2) and hypoxic (5% O2/90% N2/5% CO2) culture conditions (n = 3, N = 6). The ASCs were plated at 2,600 cells/
cm2 in 6-well plates in growth medium. Every 48 hours for 8 days,
triplicate wells were trypsinized and counted using the ViaCount
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Figure 1. Anatomic location of the intrathoracic adipose tissue depots and histological overview of the tissue ultrastructure. (A): Schematic showing the anatomical position of the pericardial and thymic remnant adipose tissue depots. (B): Intraoperative image of the intrathoracic depots
exposed through median sternotomy. (C): Representative Masson’s trichrome staining of subcutaneous, omentum, pericardial, and thymic remnant adipose tissue. Scale bars represent 100 mm. Abbreviations: OM, omentum; PF, pericardial fat; SC, subcutaneous; TH, thymic remnant.

assay with the Guava easyCyte 8HT flow cytometer, and used to
calculate the doubling time for each population.

Adipogenic Differentiation
P2 ASCs were plated at 50,000 cells/cm2 in 6-well plates and cultured
in growth medium under normoxic (95% air/5% CO2) or hypoxic
(5% O2/90% N2/5% CO2) conditions until confluent. The medium
was changed to serum-free adipogenic differentiation medium
(DMEM:Ham’s F12 supplemented with 33 mM biotin, 17 mM pantothenate, 66 nM human insulin, 1 nM triiodothyronine, 10 mg/ml
transferrin, 100 nM hydrocortisone, and 1% pen-strep). For the first
72 hours, 1 mg/ml troglitazone and 0.25 mM isobutylmethylxanthine
were added [34]. Adipogenesis was assayed at 7 days postinduction
through glycerol-3-phosphate dehydrogenase (GPDH) enzyme activity (n = 3, N = 6), as well as oil red O staining of intracellular lipid (n = 3,
N = 6), using published methods [32, 35, 36]. Negative controls maintained in growth medium were included in all assays.

Osteogenic Differentiation
P2 ASCs were plated at 20,000 cells/cm2 on laminin-coated 6-well
plates (2 mg/cm2; Sigma-Aldrich L2020) and cultured in growth
medium under normoxic (95% air/5% CO2) or hypoxic (5% O2/
90% N2/5% CO2) conditions until 70% confluence. The medium
was replaced with osteogenic differentiation medium comprised
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of growth medium supplemented with 50 mM ascorbate-2phosphate, 10 mM b-glycerophosphate, 100 nM dexamethasone, and 0.01 mM 1,25-dihydroxyvitamin D3, with medium
changes every 2–3 days [13]. Osteogenic differentiation was
assessed at 28 days after induction in terms of alkaline phosphatase (ALP) enzyme activity (n = 3, N = 6) and von Kossa staining of
matrix mineralization (n = 3, N = 6), using published methods [37,
38]. Negative control cultures maintained in growth medium
were included in all assays.

Endpoint Reverse Transcription-Polymerase Chain
Reaction Analysis
Endpoint reverse transcription-polymerase chain reaction
(RT-PCR) analysis of lineage-specific gene expression was conducted for the induced adipogenic and osteogenic cultures under normoxic (95% air/5% CO2) and hypoxic (5% O2/90% N2/5%
CO2) conditions (n = 3, N = 2) using published protocols [35].
Gene-specific primers (Life Technologies) were designed with
Primer3 software and had a melting temperature of 60°C.
Adipogenesis was assayed at 7 and 14 days post-induction
in terms of the following: PPARg (forward, 59-TTCAGAAATGCCTTGCAGTG-39, and reverse, 59-CCAACAGCTTCTCCTTCTCG-39);
C/EBPa (forward, 59-CAGAGGGACCGGAGTTATGA-39, and reverse, 59-TTCACATTGCACAAGGCACT-39); and lipoprotein lipase
S TEM C ELLS T RANSLATIONAL M EDICINE
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(LPL) (forward, 59-GTCCGTGGCTACCTGTCATT-39, and reverse,
59-TGGCACCCAACTCTCATACA-39). Osteogenesis was analyzed
at 21 and 28 days post-induction in terms of the following:
RUNX2 (forward, 59-CGGAATGCCTCTGCTGTTAT-39, and reverse,
59-TGGGGAGGATTTGTGAAGAC-39); osteonectin (ON) (forward,
59-GTGCAGAGGAAACCGAAGAG-39, and reverse, 59-AAGTGGCAGGAAGAGTCGAA-39); and bone sialoprotein (BSP) (forward,
59-AGAACCACTTCCCCACCTTT-39, and reverse, 59-AGGTTCCCCGTTCTCACTTT-39), and GAPDH (forward, 59-ACAGTCAGCCGCATCTTCTT-39, and reverse, 59-ACGACCAAATCCGTTGACTC-39)
was included as the housekeeping gene. Each PCR was carried
out for 40 cycles (95°C for 30 s, 58°C for 30 s, and 72°C for 30 s)
using a Bio-Rad C1000 thermal cycler. Expression was analyzed
following agarose gel electrophoresis and ethidium bromide staining using a Syngene G:Box Chemi HR16 system.

Statistical Analysis
Statistical analyses were carried out using GraphPad Prism version 6 (San Diego, CA). Differences were considered significant
at p , .05. To compare depot differences in the donormatched sets, Wilcoxon matched-pairs signed rank t tests were
used. Unpaired parametric two-tailed t tests with Welch’s correction were used to analyze the effect of oxygen tension or depot
for individual donors. Friedman one-way analysis of variance
(ANOVA) with a Dunn’s post hoc test was used for multiple comparisons in the matched donor sets. Kruskal-Wallis one-way
ANOVA with a Dunn’s post hoc test was used for multiple comparisons between depots.

RESULTS
Tissue Ultrastructure
There were differences in the tissue ultrastructure of each depot
(Fig. 1). In the matched donor sets, the omentum was macroscopically less stiff and more vascularized than abdominal
subcutaneous adipose tissue. Masson’s trichrome staining confirmed that subcutaneous fat contained more fibrous connective tissue, with fewer blood vessels distributed through the
collagen (Fig. 1C). The pericardial and thymic remnant samples
were macroscopically similar, although the thymic remnant
appeared more fibrous in younger patients (,60 years). However, Masson’s trichrome staining revealed that the thymic remnant had much higher complexity, generally containing more
fibrous collagen, large blood vessels, and regions enriched in immune cells (Fig. 1C).

Viable SVF Yield Is Depot Dependent
The average viable cell yield in the SVF was calculated per gram of
digested tissue for all depots (Fig. 2A). The numerical values for all
graphical data shown in Figure 2 are summarized in supplemental
online Table 2. A significantly higher yield was obtained from the
omentum as compared with subcutaneous fat for all of the donors.
Similarly, the thymic remnant had a higher average yield than pericardial adipose tissue, but the values were more variable and not
statistically different (Fig. 2A).Pericardial adipose tissue had a lower
average percentage viability in the SVF than the thymic remnant
(72.8% 6 4.2% versus 82.5% 6 5.4%) (Fig. 2B). In comparing the
matched donor samples, this difference was statistically significant
for all patients, with the exception of donor 4. No trends were
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noted in terms of the effect of donor age or BMI on the SVF yield
or percent viability.

CD34 and CD166 Expression in Cultured ASCs Varies
Depending on the Adipose Tissue Source
Representative surface marker expression profiles for P2 ASCs
from each depot are shown in Figure 3. Subcutaneous and omentum samples were collected from four male and two female
donors with an average age of 56 6 22 years, and the pericardial
adipose and thymic remnant samples were collected from five
male donors and one female donor with an average age of 70
6 12 years. All populations were strongly positive for CD44,
CD73, CD90, and CD29, with very low expression of CD31 and
CD4. Analysis of CD4 was included to confirm absence of expression in the populations from the thymic remnant.
Whereas cultured ASCs from subcutaneous fat or the omentum did not express CD34, 81% 6 21% and 47% 6 25% of P2 ASCs
from pericardial adipose tissue and thymic remnant, respectively,
were CD34+ (Fig. 3B), with the pericardial depot having significantly higher expression than all other depots. A significantly
higher percentage of P2 ASCs isolated from subcutaneous adipose
tissue was CD166+, with an overall average of 82% 6 18%, as compared with 37% 6 17% for the omentum. CD166 expression was
typically lower in the ASCs derived from pericardial adipose tissue
(average 60% 6 25%) than from the thymic remnant (average
72% 6 20%), but the difference was not statistically significant.

In Vitro Clonogenic Potential Is Enhanced Under
Hypoxic Conditions
In the matched donor sets, there was a trend for higher CFE in
ASCs from subcutaneous fat versus the omentum, and also for
ASCs from pericardial adipose tissue versus the thymic remnant
(Fig. 2C). In comparing all depots, there was a significant difference in CFE between the subcutaneous and thymic remnant samples under both normoxic and hypoxic conditions. Furthermore,
colony formation was enhanced for all depots under hypoxic culture conditions (Fig. 2C). Although the average CFE was lower for
the ASCs from the intrathoracic depots, the pericardial and thymic
remnant ASCs were more susceptible to the inductive effects of
hypoxia, showing a higher percentage increase in colony formation under hypoxic conditions (supplemental online Fig. 1A).

ASCs Isolated From the Intrathoracic Depots Have
a Longer Average Doubling Time
ASCs from the intrathoracic depots had a longer average doubling
time than ASCs from the subcutaneous/omentum donors, although the difference was only statistically significant relative to
the omentum (Fig. 2D). For the donors in our study, we did not
observe any specific trends between donor age and proliferative
capacity. Under the current study conditions, the proliferation
rate was not affected by the oxygen tension in the culture
environment.

Subcutaneous ASCs Demonstrate Enhanced Adipogenic
Differentiation Relative to ASCs Derived From
the Omentum
The P2 ASCs isolated from the subcutaneous depot had a significantly higher GPDH activity level than the ASCs isolated from
the omentum for four of the six donors (Fig. 4A). Moreover,
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Figure 2. Data summary for average values for all donors for each of the depots. All data are expressed as mean 6 SD. p, Significantly different at
(p , .05). (A): Viable cell yield per gram of digested tissue (n = 3, N = 7). (B): Percent viability in stromal vascular fraction (n = 3, N = 7). (C): In vitro
clonogenic potential measured through the colony-forming unit-fibroblast assay at 14 days (n = 3, N = 3). (D): Doubling time of P2 ASCs (n = 3, N =
6). (E): GPDH enzyme activity at 7 days post-induction of adipogenic differentiation (n = 3, N = 6). (F): ALP enzyme activity at 28 days post-induction of osteogenic differentiation (n = 3, N = 6). Abbreviations: ALP, alkaline phosphatase; CFE, colony-forming efficiency; GPDH, glycerol3-phosphate dehydrogenase; H, hypoxic (5% O2/90% N2/5% CO2); N, normoxic (95% air/5% CO2); OM, omentum; PF, pericardial fat; SC,
subcutaneous; TH, thymic remnant.

except for donor 5, the GPDH activity levels for the induced
omental ASCs were the same as the non-induced controls, indicating that the cells were not undergoing adipogenesis. In the
subcutaneous samples, lower GPDH levels were observed for
more severely obese donors (BMI . 30) (Fig. 4C), whereas
low levels were observed for all omentum samples regardless
of BMI (Fig. 4D). Average GPDH activity levels for all depots
are highlighted in Figure 2E. The GPDH results were confirmed
with oil red O staining, which showed extensive intracellular
lipid in the subcutaneous ASCs, which qualitatively correlated
with the GPDH activity level (Fig. 4B). In contrast, no positive
staining was observed in the omental ASCs at 7 days, with the
exception of the donor 5 sample, which showed a small fraction
of differentiating cells.
Based on the GPDH and oil red O data, oxygen tension did not
have a major impact on adipogenic differentiation in the subcutaneous and omentum samples at 7 days, although GPDH activity
was reduced in the subcutaneous ASCs from donors 1 and 4 under
hypoxic conditions (statistically significant for donor 4) (Fig. 4A).
In terms of gene expression (Fig. 4E), the master adipogenic
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regulator PPARg and the late marker LPL were expressed at 7
and 14 days in all induced subcutaneous ASC samples. C/EBPa expression was lower at 7 days under hypoxic conditions in this
group. In contrast, for the omentum, whereas PPARg was
expressed at both time points with qualitatively higher expression
under normoxic conditions, C/EBPa was only detected under normoxic conditions and was expressed at very low levels at 7 days.
Similarly, LPL was expressed strictly in the normoxic samples at 14
days. These patterns suggest a lower level of adipogenic differentiation in the hypoxic cultures.

Pericardial ASCs Demonstrate Enhanced Adipogenic
Differentiation Relative to ASCs Derived From the
Thymic Remnant
For the pericardial and thymic remnant samples, GPDH activity
was observed in the pericardial ASCs but not in the donormatched thymic remnant ASCs from donors 3 and 4 (Fig. 5A).
Furthermore, for the ASCs derived from the thymic remnant
from donors 1, 3, and 4, the GPDH activity was the same as
S TEM C ELLS T RANSLATIONAL M EDICINE
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Osteogenic Differentiation Is Enhanced in ASCs Isolated
From the Omentum and Under Normoxic
Culture Conditions

Figure 3. Immunophenotype of P2 ASCs isolated from each of the
depots. (A): Representative histograms of donor-matched subcutaneous/omentum samples and donor-matched pericardial fat/thymic
remnant samples. (B): Percentage of positive cells for each of the
markers analyzed. Data are presented as the mean 6 SD (n = 3,
N = 6). Interdepot differences in the expression were observed for
CD34 and CD166. p, Statistically significant (p , .05). Abbreviations:
OM, omentum; PF, pericardial fat; SC, subcutaneous; TH, thymic
remnant.

the non-induced controls, indicating that the cells were not undergoing adipogenesis. For donor 1, no significant differentiation was also observed for the pericardial ASCs. The GPDH
activity was not clearly correlated with the BMI for the intrathoracic depots, although all of the donors had a BMI , 30 (Fig. 5C,
5D). Intracellular lipid was observed for ASCs from both intrathoracic depots under normoxic and hypoxic conditions for all
samples with a GPDH activity .5 mU/mg intracellular protein
(Fig. 5B).
In terms of oxygen tension, GPDH activity was reduced in the
pericardial ASCs under hypoxic conditions for three of six of the
donors (statistically significant for donors 3 and 6) (Fig. 5A). Similarly, the GPDH activity for the thymic remnant ASCs from the
three donors that responded was negatively affected by hypoxic
culturing, but this difference was only statistically significant in
donor 6. In terms of adipogenic gene expression, all markers were
detected under normoxic and hypoxic culture conditions for both
intrathoracic depots (Fig. 5E).

www.StemCellsTM.com

For the subcutaneous and omentum ASCs, ALP enzyme activity
(Fig. 6A) was significantly enhanced in all donor sets as compared
with the non-induced controls. Under normoxic conditions, there
was a trend toward higher average ALP enzyme activity in the
omental ASCs (Fig. 2F). In the donor-matched analysis, the normoxic ALP activity was consistently higher for the omentum samples, and this difference was statistically significant for donors 2–5
(Fig. 6A). For both depots, the ALP enzyme activity was significantly lower in the cells cultured under hypoxic culture conditions
(Figs. 2F, 6A). The von Kossa staining results were more variable.
In donors 2 and 5, matrix mineralization was only observed in the
omental ASCs (Fig. 6C). For the other donors, the effects of oxygen
tension on matrix mineralization were consistent with the trends
in ALP activity, with larger deposits observed under normoxic conditions for both depots (Fig. 7B). In terms of osteogenic gene expression (Fig. 7C), RUNX2 and ON were expressed at similar levels
in the ASCs from both depots at 21 and 28 days, with slightly enhanced RUNX2 expression under normoxic conditions for the subcutaneous samples at 28 days. BSP expression was only detected
at low levels under normoxic conditions in the subcutaneous ASCs
at 28 days, as well as at qualitatively higher levels in the omentum
samples at 21 days.
For the intrathoracic samples, the average ALP enzyme activity levels were similar for both depots (Fig. 2F). However, in
the donor-matched analysis, significantly higher ALP activity
was noted under normoxic conditions in the pericardial ASCs
from donors 2, 4, and 6 (Fig. 7A). All induced cultures stained
positively for matrix mineralization (Fig. 7B), with the exception of the donor 6 samples. Similar to the subcutaneous and
omental ASCs, osteogenic differentiation was reduced under
hypoxic conditions (Fig. 7A, 7B). In the gene expression studies
(Fig. 7C), RUNX2 and ON were expressed in both sample
groups, at qualitatively higher levels at 28 days. BSP was
expressed under normoxic conditions for both depots at 21
and 28 days, as well as in the pericardial ASCs cultured under
hypoxic conditions at 28 days.
In comparing all four depots, the omentum had the highest
average ALP activity levels of all four depots, although the differences were not statistically significant (Fig. 2F). Furthermore, it
was noted that there were differences in the sensitivity of the cell
populations to the hypoxic culture conditions between depots
(supplemental online Fig. 1B). More specifically, the percentage
decrease in average ALP activity under hypoxic conditions versus
normoxic conditions was more pronounced for the ASCs from the
intrathoracic depots.

Intrathoracic ASCs Undergo Adipogenic Differentiation
in Osteogenic Culture Conditions
Interestingly, extensive intracellular lipid accumulation was observed in the osteogenic studies with the pericardial and thymic
remnant ASCs from donors 2, 4, and 5 under normoxic conditions, suggesting that these cells were predisposed toward
the adipogenic lineage (supplemental online Fig. 2). No evidence of adipogenesis was observed in any of the osteogenic
cultures for the ASCs from subcutaneous adipose tissue or the
omentum.
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Figure 4. Adipogenic differentiation of ASCs isolated from subcutaneous fat and the omentum. (A): GPDH enzyme activity of induced donormatched P2 ASCs at 7 days. Data are expressed as mean 6 SD (n = 3, N = 6). p, Significantly different (p , .05). (B): Representative oil red O
staining at 7 days post-induction. Intracellular lipid accumulation was observed under both oxygen conditions for subcutaneous ASCs, but not
ASCs derived from the omentum or the negative controls. Scale bars represent 100 mm. Relationship between GPDH activity and donor BMI for
ASCs derived from subcutaneous adipose tissue (C) and omentum (D). Crossed values (x) indicate nonmatched donor samples not included in the
comparative assessments. (E): Representative endpoint RT-PCR analysis of adipogenic gene expression at 7 and 14 days (n = 3, N = 2) with GAPDH
as the housekeeping gene. Abbreviations: BMI, body mass index; GPDH, glycerol-3-phosphate dehydrogenase; H, hypoxic (5% O2/90% N2/5%
CO2); N, normoxic (95% air/5% CO2); OM, omentum; SC, subcutaneous.

DISCUSSION
In obesity and metabolism research, depot- and donordependent differences in adipose tissue structure and function,
along with variations in the mature adipocyte and adipose progenitor populations, have long been recognized [18, 39–41]. In
terms of the clinical translation of cellular therapies involving
ASCs, these studies highlight that “all fat is not equal” and emphasize the importance of consideration of adipose depot selection. A better understanding of the characteristics of ASCs from
different depots and donors will help to identify whether a specific fat source is more promising for certain regenerative applications. If an autologous approach is to be applied, there are
many other influencing factors, including donor health status,
tissue availability and accessibility, and timing, as well as cost
of treatment.
The majority of comparative studies to date have focused on
assessing differences in proliferation and adipogenic differentiation in cells isolated from subcutaneous adipose tissue and the
omentum [14, 18, 39–41]. A smaller number of studies have looked
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at the effects of adipose source on osteogenic potential [16, 42, 43].
Interestingly, there is no clear consensus in terms of the specific
trends for proliferation or differentiation, and the results from different groups can appear contradictory. However, there is a lack of
standardization in methods, including cell extraction protocols, culture conditions, and passage number, as well as inherent variability
in the donor populations, which can make it difficult to compare the
data. Furthermore, in reviewing past work, it becomes clear that it
is advantageous to use a range of characterization assays to more
fully understand the observed cellular responses.
With this guiding principle, we applied consistent methods to
more deeply probe the influence of adipose tissue depot source on
the human ASC populations. Subcutaneous fat is the most widely
investigated ASC source, due to its abundance and ease in acquisition. However, the omentum has long been recognized for its
unique angiogenic properties, and omental flaps have been used
in many clinical applications to stimulate blood vessel formation
and healing, which may suggest the presence of distinct regenerative cell populations [44–47]. In the context of heart surgery
through a sternotomy, pericardial adipose tissue and the thymic
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Figure 5. Adipogenic differentiation of ASCs isolated from pericardial and thymic remnant adipose tissue. (A): GPDH enzyme activity of induced
donor-matched P2 ASCs at 7 days. Data are expressed as mean 6 SD (n = 3, N = 6). p, Significantly different (p , .05). (B): Representative oil red O
staining at 7 days post-induction. Scale bars represent 100 mm. Relationship between GPDH activity and donor BMI for ASCs derived from pericardial adipose tissue (C) and thymic remnant (D). (E): Representative endpoint RT-PCR analysis of adipogenic gene expression at 7 and 14 days
(n = 3, N = 2) with GAPDH as the housekeeping gene. Abbreviations: BMI, body mass index; GPDH, glycerol-3-phosphate dehydrogenase; H,
hypoxic (5% O2/90% N2/5% CO2); N, normoxic (95% air/5% CO2); PF, pericardial fat; TH, thymic remnant.

remnant become accessible, expendable, and often abundant
adipose sources that could be used in cell therapies for cardiovascular regeneration. Previous studies have identified multipotent
cell populations in epicardial fat, which is closely interconnected
with the myocardium [19], and in the thymus of pediatric [48]
and adult [49] donors. However, pericardial adipose tissue, as well
as the thymic remnant from elderly donors, have not yet been explored as ASC sources. Furthermore, to the best of our knowledge,
this is the first comparative adipose depot study to assess the
effects of oxygen tension by comparing the ASC responses under
normoxic and hypoxic culture conditions.
In terms of yield, the number of viable cells in the SVF from the
omentum was significantly higher than from abdominal subcutaneous adipose tissue, which is consistent with the findings of van
Harmelen et al. [41] and may be attributable to the presence of
more endothelial cells in the richly vascularized omentum. For
the intrathoracic depots, there was substantial donor variability
in the thymic remnant samples. Combined with the histological
results, it is likely that this difference in the SVF yield is at least partly
associated with the presence of other cell types, such as lymphocytes, that were not eliminated during the extraction process.
Flow cytometric analysis of P2 ASCs showed that, consistent
with the literature, all cultured ASCs were positive for CD44,
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CD73, CD90, and CD29, with very low expression of CD31 and
CD4 [50–52]. CD166 expression was more variable, but the patterns are in line with previous reports of low expression of this
adhesion molecule in the SVF of subcutaneous ASCs, with enhanced expression through successive passaging [51, 53]. Similarly, several studies have demonstrated that SVF from
subcutaneous adipose tissue and the omentum contains CD34+
populations, but expression decreases substantially during culturing [15, 51, 54]. However, we found that a high percentage
of P2 ASCs from the intrathoracic depots was CD34+ after expansion. This enhanced CD34 expression may be favorable for cardiovascular cell therapy. More specifically, testing in animal models
of chronically ischemic myocardium has provided evidence of the
safety and efficacy of intramyocardial transplantation of CD34+enriched cell suspensions for promoting neovascularization
[55–57]. Based on these findings, recent clinical trials have focused on strategies with autologous CD34+ bone marrowderived MSCs in patients with refractory angina [58] and myocardial infarction [59], with significant improvements noted in angina
frequency and exercise tolerance in the first study and a dose
response observed in terms of the number of injected CD34+
cells and increased left ventricular ejection fraction in the
second.
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Figure 6. Osteogenic differentiation of ASCs isolated from subcutaneous fat and the omentum. (A): ALP enzyme activity of induced donormatched P2 ASCs at 28 days. Data are expressed as mean 6 SD (n = 3, N = 6). With the exception of donor 1 (SC), donor 5 (OM), and donor
6 (SC + OM), a significant difference was observed in ALP activity in both depots under normoxic versus hypoxic conditions. p, Significant difference between donor-matched subcutaneous and omentum ASCs (p , .05). (B): Representative von Kossa staining at 28 days post-induction.
Matrix mineralization was observed in all induced samples, but was dramatically reduced under hypoxic conditions for both depots. Scale bars
represent 100 mm. (C): In donors 2 and 5, matrix mineralization was observed in ASCs isolated from the omentum but not subcutaneous fat. Scale
bars represent 100 mm. (D): Representative endpoint RT-PCR analysis of osteogenic gene expression at 21 and 28 days (n = 3, N = 2) with GAPDH
as the housekeeping gene. Abbreviations: ALP, alkaline phosphatase; H, hypoxic (5% O2/90% N2/5% CO2); N, normoxic (95% air/5% CO2); OM,
omentum; SC, subcutaneous.

In terms of in vitro clonogenic potential, it was interesting that
the P2 ASCs derived from subcutaneous adipose tissue and the
omentum formed more colonies on average in the CFU-F assay,
despite having lower levels of CD34 expression than the ASCs derived from pericardial adipose tissue and thymic remnant. Previous work with subcutaneous ASCs and bone marrow-derived
MSCs has indicated that there is a positive correlation between
CD34 expression and colony formation [60–62]. However, our
results are consistent with our proliferation data, which showed
that the intrathoracic ASCs had longer average doubling times. Although the proliferation rates were not altered under the level of
hypoxia used in our study, there was enhanced colony formation
observed for all depots when the cells were cultured at 5% O2.
These results are similar to past studies demonstrating the positive effects of hypoxia on colony formation for bone marrowderived MSCs [63, 64].
In terms of adipogenesis, our donor-matched subcutaneous
and omentum results were consistent with published studies indicating that subcutaneous ASCs are more adipogenic than
those derived from the omentum [15, 16, 18, 41]. Interestingly,
unlike ASCs from epicardial adipose tissue that reportedly do
not differentiate into adipocytes [19], the cells derived from
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both pericardial adipose tissue and thymic remnant could be
stimulated to undergo adipogenic differentiation, although the
thymic remnant results were more inconsistent. In general,
there was donor variability in the GPDH activity levels observed
for all depots, which may be attributable to a multitude of factors, including gender, age, and BMI, as well as insulin sensitivity
[65]. In terms of the effect of oxygen tension on adipogenic differentiation, GPDH activity and intracellular lipid accumulation
were not majorly influenced by culturing at 5% O2 for most of the
donors. However, there was a trend toward reduced enzyme activity under hypoxic conditions, as well as some differences in
the gene expression patterns for the subcutaneous and omentum ASCs, which may suggest that hypoxia had a slight negative
impact on adipogenesis. Based on the results of Lin et al. and Lee
and Kemp [27, 66], it is possible that further reductions in the
oxygen levels to 1% or 2% could more profoundly influence
the adipogenic response.
In our study, which is the first to compare ASCs extracted from
matched subcutaneous/omentum fat and matched intrathoracic
adipose tissue under varying oxygen levels, osteogenic differentiation was enhanced in the omental ASCs relative to all other
depots. The lack of mineralization observed in some subcutaneous
S TEM C ELLS T RANSLATIONAL M EDICINE

Russo, Yu, Belliveau et al.

215

Figure 7. Osteogenic differentiation of ASCs isolated from pericardial adipose tissue and the thymic remnant. (A): ALP enzyme activity of induced donor-matched P2 ASCs at 28 days. Data are expressed as mean 6 SD (n = 3, N = 6). For all donors, a significant difference was observed for
both depots under normoxic versus hypoxic conditions. p, Significant difference between donor-matched pericardial and thymic remnant ASCs
(p , .05). (B): Representative von Kossa staining at 28 days post-induction. Matrix mineralization was observed in all induced samples, but was
reduced under hypoxic conditions for both depots. Scale bars represent 100 mm. (C): Representative endpoint RT-PCR analysis of osteogenic
gene expression at 21 and 28 days (n = 3, N = 2) with GAPDH as the housekeeping gene. Abbreviations: ALP, alkaline phosphatase; H, hypoxic (5%
O2/90% N2/5% CO2); N, normoxic (95% air/5% CO2); PF, pericardial fat; TH, thymic remnant.

samples, despite elevated ALP activity, emphasizes the importance
of analyzing multiple differentiation markers. The enhanced osteogenic activity combined with the reduced adipogenic capacity of
the omental ASCs may be indicative that the heterogeneous population includes progenitors that have more restricted potential in
culture and are predisposed toward the osteogenic lineage, as has
been observed with MSCs derived from human bone marrow
[67–70]. Consistent with the results of He et al. and Merceron
et al. [26, 30], ALP activity and mineral deposition were inhibited
when the cells were cultured at 5% O2 for all depots. These results
are concordant with the fact that under physiological conditions
bone is highly vascularized and that vascularization is key for normal bone development [71].
For three donors under normoxic conditions, the intrathoracic ASCs accumulated substantial intracellular lipid under osteogenic differentiation conditions, which may be related to the
dexamethasone in the osteogenic formulation, as this potent corticosteroid can have inductive effects on both osteogenic and adipogenic pathways [72, 73]. Furthermore, whereas vitamin D3 has
been used to stimulate osteogenic differentiation of ASCs [74], it
can have diverse effects on different cell populations and has
been shown in previous studies with fetal rat calvaria cells to promote adipogenesis synergistically with dexamethasone and inhibit osteogenesis [75, 76]. This phenomenon was only observed
in the intrathoracic ASCs, and the differential response may indicate that these populations are more committed toward the adipogenic lineage.

CONCLUSION
The results of our study emphasize the relevance of depot selection in the development of autologous or allogenic cell-based
regenerative strategies with ASCs. Although there was donor

www.StemCellsTM.com

variability, particularly in the adipogenic and osteogenic differentiation levels, notable differences were observed between the
populations isolated from the subcutaneous, omentum, and intrathoracic depots. Moreover, we have shown for the first time
that ASCs can be extracted from pericardial adipose tissue and
the thymic remnant and that these cells have unique characteristics, including enhanced CD34 expression at P2 and increased
sensitivity to hypoxic culture conditions. Of the intrathoracic
depots studied, the pericardial ASC population was more homogenous and may have potential clinical utility in cardiovascular
applications. The enhanced osteogenic capacity of the omentum,
combined with its reduced adipogenic differentiation potential,
suggests that omental ASCs may hold particular promise for bone
regeneration strategies.
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